The Killer Combo
May 28, 2019
A longer-lasting strategy to rejuvenate existing antibiotics with synergistic combinations is likely to play an integral role in the development of treatments against antibiotic resistant pathogens.
0 min read

May 28, 2019
A longer-lasting strategy to rejuvenate existing antibiotics with synergistic combinations is likely to play an integral role in the development of treatments against antibiotic resistant pathogens.
0 min read
May 28, 2019
Chad A. Mirkin, Professor of Chemistry at Northwestern University, discusses why spherical nucleic acids are so exciting for drug development
0 min read
May 28, 2019
Academics have a role to play in the acceleration of biomedical innovation. And SPARK, a translational research program at Stanford University is proving how important academicians are in slashing the time taken to bring novel therapeutics to market.
0 min read
May 28, 2019
The cannabis business is booming as century-old legal conventions restricting use begin to unravel. Can pharma ride the wave with cannabis-based medicines? And how will drugmakers entering the fray deal with the dosage, delivery and bioavailability challenges?
0 min read
May 13, 2019
Could aquatic bacteria hold the keys to bolstering our drug pipelines?
0 min read
May 13, 2019
Social responsibility at its finest, AI partnerships, and a crack down on vaccine manufacturing malpractice... What’s new for pharma in business?
0 min read
May 13, 2019
A new publication will give the small molecule manufacturing community the attention and praise it deserves. Meet The Small Molecule Manufacturer.
0 min read
May 13, 2019
Answer: anything that will fit! A competition challenges artists to create a masterpiece that fits inside a pharmaceutical capsule
0 min read
May 13, 2019
ADCs have suffered a few setbacks over the years, but interest in their therapeutic potential – particularly against cancer – remains high.
0 min read
May 13, 2019
Innovation in glass continues to be a key enabler for allowing pharma manufacturers to make better, safer products for patients. This has been SCHOTT’s mantra for more than 130 years – why stop now?
0 min read
False
False